Delivery Order SPE2DB22D1017-SPE2DB25FF9UQ

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,373.43 firm fixed price delivery order is for the supply of RECTIV 0.4% ointment, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4562283859 RECTIV 0.4% OINTMENT 30GM. The $1,916.34 fixed-price Delivery Order contract has a completion date of September 25, 2023. This contract is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,017.55, is a delivery order for 4567175522 RECTIV 0.4% OINTMENT 30GM. It is a firm-fixed price contract with a completion date of February 6, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568082307 RECTIV 0.4% OINTMENT 30GM. The $1,345.90 contract has a performance period through May 1, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,776.34 firm fixed-price delivery order is for the supply of "RECTIV 0.4% OINTMENT 30GM" medical products. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,287.63 firm fixed-price delivery order is for the supply of RECTIV 0.4% OINTMENT 30GM, a medical product. The award has an ultimate completion date of June 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of RECTIV 0.4% OINTMENT 30GM. The $1,675.94 firm fixed-price delivery order contract has a completion date of February 7, 2024. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $53,149.57, is for the delivery of RECTIV 0.4% OINTMENT (federal stock number 4566362003) to support military healthcare programs. The contract is a firm fixed-price delivery order with a completion date of December 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,528.97, is for the delivery of RECTIV 0.4% ointment in 30-gram quantities. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,236.97 firm fixed-price delivery order is for the supply of "RECTIV 0.4% OINTMENT 30GM" medical products. The contract has an ultimate completion date of June 12, 2024 and was awarded on June 11, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF9UQ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,319.20 firm fixed-price delivery order, identified as SPE2DB22D1017|SPE2DB25FF9UQ, is for the supply of 4567872119 RECTIV 0.4% OINTMENT 30GM. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, designated as SPE2DX, which provides comprehensive global pharmaceutical support to military healthcare programs through December 2026. The contract is not set aside and allows for multiple orders across different therapeutic categories, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for the Defense Health Agency, U.S. Coast Guard, and other government agencies.

Generated 7/17/25, 6:01 PM